FDA Approved: ZETIA — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Dyslipidemia
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Zetia (ezetimibe)

Snippet

SUPPL AP for ZETIA (EZETIMIBE)